ArticleVaccines2026

A Randomized Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Bivalent RSVpreF Vaccine in Older Adults in Korea.

Won Suk Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.